ArticleMolecular psychiatry2026
Positive bias in brain and behaviour as a mechanism of transcranial magnetic stimulation depression treatment.
Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Transcranial magnetic stimulation (TMS) is a novel approved therapy for treatment-resistant depression. Little is known about its neurocognitive mechanisms of action. The existing literature has focused on resting-state neuroimaging. It therefore remains unknown what information processing changes TMS induces during treatment that drive mood change. Here we tested the hypothesis that transcranial magnetic stimulation (TMS) treatment changes emotional bias, increasing the focus on positive (versus negative) information processing. 49 patients with major depression received 20 daily sessions of open-label intermittent theta-burst TMS to left dorsolateral prefrontal cortex. Emotional bias was measured using behavioural and functional magnetic resonance imaging tasks of emotional face processing, both at baseline and after eight days of treatment. We tested whether early changes in these measures after the first week predicted clinical outcome at the end of treatment (4 weeks). As predicted, an increase in behavioural and neural measures of positive bias after one week predicted clinical response after four weeks of treatment. Behaviourally, response to TMS treatment was associated with a bias towards interpreting ambiguous facial expressions as positive. Neurally, clinical improvement was related to increased neuroimaging response for the contrast of positive versus negative emotional faces in rostral anterior cingulate cortex (rACC), and a positive bias in task-related functional connectivity between rACC and posterior default mode network. These early neurocognitive changes predicted clinical outcomes after four weeks of treatment, beyond early symptom reduction. Thus, clinical response to TMS treatment was linked to increases in positive bias in emotional processing early during treatment which might represent a neurocognitive mechanism of TMS depression treatment, potentially neurally distinct from antidepressant drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.